We are live on ! Find out more
CHAC.U

Chardan Healthcare Acquisition Corp.

Delisted

CHAC.U was delisted on the 25th of October, 2019.

8 hedge funds and large institutions have $10.4M invested in Chardan Healthcare Acquisition Corp. in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% less funds holding

Funds holding: 178 (-9)

55% less capital invested

Capital invested by funds: $23M → $10.4M (-$12.7M)

89% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 9

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
-9
Holders Change %
-52.94%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
9
Calls
Puts
Net Calls
Net Calls Change

CHAC.U Hedge Fund Activity: Q3 2019 in Review

8 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Chardan Healthcare Acquisition Corp. (CHAC.U) for Q3 2019, worth a combined $10.4M — down 55% from $23M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CHAC.U and 1 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was K2 Principal Fund, exiting entirely with an estimated $3.74M sold.

  • 8 institutional investors held Chardan Healthcare Acquisition Corp. (CHAC.U) as of Q3 2019, down from 17 in Q2 2019.
  • Funds reported $10.4M of Chardan Healthcare Acquisition Corp. stock for Q3 2019, down 55% quarter-over-quarter.
  • 1 fund opened new Chardan Healthcare Acquisition Corp. positions in Q3 2019 and 9 closed out, a net change of -8 holders.
  • The largest Chardan Healthcare Acquisition Corp. seller in Q3 2019 was K2 Principal Fund, an estimated $3.74M sold.

Based on aggregated 13F filings for Q3 2019.